Skip to content

Clinical trials

Observational Hepatitis C trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Observational Clear all

450 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20024
20034
200411
200520
200613
200712
200817
200915
201016
201122
201224
201318
201418
201531
201628
201730
201830
201926
202014
202113
202214
202317
202412
202510
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed255
Unknown status106
Terminated31
Recruiting23
Withdrawn17
Not yet recruiting11
Active, not recruiting4
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC23
AbbVie15
Assiut University12
Gilead Sciences12
ANRS, Emerging Infectious Diseases11
Bristol-Myers Squibb11
National Taiwan University Hospital11
Kirby Institute7
National Institute of Allergy and Infectious Diseases (NIAID)7
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C450
Hepatitis C, Chronic73
Hepatitis B57
HIV Infections37
Acquired Immunodeficiency Syndrome32
Carcinoma, Hepatocellular24
Fibrosis21
Liver Cirrhosis18
Hepatitis17
Liver Diseases15

Trials

Showing 51 to 75 of 450. Each trial links to its page on Pharma Observatory.

350 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.